nifedipine and 3,4-dihydroxyphenylacetic acid

nifedipine has been researched along with 3,4-dihydroxyphenylacetic acid in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's4 (40.00)18.2507
2000's5 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Basile, AS; Bolger, GT; Lesieur, P; Skolnick, P1
Dall'Olio, R; Gaggi, R; Gianni, AM; Roncada, P1
Etou, K; Hirano, M; Kuroki, T; Tashiro, N; Tatebayashi, Y1
Alfaro, MJ; Martín, MI; Martín, S; Ormazabal, MJ; Viveros, MP1
Antkiewicz-Michaluk, L; Romańska, I; Vetulani, J1
Armando, I; Belforte, JE; Buño, W; Magariños-Azcone, C; Pazo, JH1
Afailal, I; El Ayadi, A; Errami, M1
Hashimoto, T; Yabe-Nishimura, C1

Other Studies

10 other study(ies) available for nifedipine and 3,4-dihydroxyphenylacetic acid

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain.
    Brain research, 1988, Jan-12, Volume: 438, Issue:1-2

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dihydropyridines; Dopamine; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Ion Channels; Male; Mice; Neurotransmitter Agents; Nifedipine

1988
Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system.
    General pharmacology, 1995, Volume: 26, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium Channel Blockers; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Injections, Intraperitoneal; Isradipine; Male; Motor Activity; Nifedipine; Nimodipine; Parietal Lobe; Rats; Rats, Sprague-Dawley

1995
Effects of calcium antagonists nifedipine and flunarizine on phencyclidine-induced changes in the regional dopaminergic metabolism of the rat brain.
    Biochemical pharmacology, 1996, Jan-12, Volume: 51, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Mapping; Calcium Channel Blockers; Dopamine; Flunarizine; Hallucinogens; Homovanillic Acid; Male; Nifedipine; Phencyclidine; Rats; Rats, Inbred Strains

1996
Effects of nimodipine and nifedipine upon behavior and regional brain monoamines in the rat.
    Psychopharmacology, 1996, Volume: 127, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Calcium Channel Blockers; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Nifedipine; Nimodipine; Rats; Rats, Wistar; Serotonin

1996
Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures.
    Psychopharmacology, 1996, Volume: 128, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Calcium Channel Blockers; Cerebral Cortex; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Nifedipine; Nucleus Accumbens; Rats; Rats, Wistar; Verapamil

1996
Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.
    Parkinsonism & related disorders, 2001, Volume: 8, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Calcium Channel Blockers; Calcium Channels, L-Type; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Flunarizine; Haloperidol; Male; Microinjections; Neostriatum; Nifedipine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Synapses; Synaptic Transmission

2001
Effects of voltage-sensitive calcium channel blockers on extracellular dopamine levels in rat striatum.
    Metabolic brain disease, 2001, Volume: 16, Issue:3-4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium Channel Blockers; Calcium Channels; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Extracellular Space; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Neomycin; Nifedipine; omega-Conotoxins; Potassium; Rats; Rats, Sprague-Dawley; Time Factors

2001
Oxidative metabolite of dopamine, 3,4-dihydroxyphenylacetaldehyde, induces dopamine release from PC12 cells by a Ca2+-independent mechanism.
    Brain research, 2002, Mar-22, Volume: 931, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium; Calcium Channel Blockers; Dopamine; L-Lactate Dehydrogenase; Nifedipine; Oxidation-Reduction; Parkinson Disease; PC12 Cells; Rats

2002